ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01206296
Recruitment Status : Terminated (Study suspended)
First Posted : September 21, 2010
Last Update Posted : December 9, 2015
Sponsor:
Information provided by (Responsible Party):
Washington Hospital Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2014
  Actual Study Completion Date : February 2014